Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluation

Gao, Lan and Li, Shu-Chuen 2018, Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluation, Breast cancer, pp. 1-10, doi: 10.1007/s12282-018-0872-6.

Attached Files
Name Description MIMEType Size Downloads

Title Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluation
Author(s) Gao, LanORCID iD for Gao, Lan orcid.org/0000-0001-9734-1140
Li, Shu-Chuen
Journal name Breast cancer
Start page 1
End page 10
Total pages 10
Publisher Springer
Place of publication Berlin, Germany
Publication date 2018-05-25
ISSN 1880-4233
Keyword(s) Breast cancer
Cost-effectiveness analysis
Granulocyte colony-stimulating factor (G-CSF)
Primary prophylaxis
Notes In Press
Language eng
DOI 10.1007/s12282-018-0872-6
Field of Research 1112 Oncology And Carcinogenesis
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2018, Springer
Persistent URL http://hdl.handle.net/10536/DRO/DU:30108993

Document type: Journal Article
Collection: Population Health
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 0 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 22 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Tue, 05 Jun 2018, 10:10:11 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.